BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33051117)

  • 21. Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States.
    Rich NE; Yopp AC; Singal AG; Murphy CC
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):242-248.e5. PubMed ID: 31042582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
    Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
    Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors associated with suicide among esophageal carcinoma patients from 1975 to 2016.
    Chen C; Lin H; Xu F; Liu J; Cai Q; Yang F; Lv L; Jiang Y
    Sci Rep; 2021 Sep; 11(1):18766. PubMed ID: 34548616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma in children: epidemiology and the impact of regional lymphadenectomy on surgical outcomes.
    McAteer JP; Goldin AB; Healey PJ; Gow KW
    J Pediatr Surg; 2013 Nov; 48(11):2194-201. PubMed ID: 24210185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance for Violent Deaths - National Violent Death Reporting System, 34 States, Four California Counties, the District of Columbia, and Puerto Rico, 2017.
    Petrosky E; Ertl A; Sheats KJ; Wilson R; Betz CJ; Blair JM
    MMWR Surveill Summ; 2020 Dec; 69(8):1-37. PubMed ID: 33270620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of nativity with survival among adults with hepatocellular carcinoma.
    Zhou K; Song Z; Rostomian N; Dodge JL; Stern MC; Setiawan VW; Terrault NA; Cockburn MG; Liu L
    J Natl Cancer Inst; 2023 Jul; 115(7):861-869. PubMed ID: 37160726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Māori: results from a 28-year follow-up study.
    Lim TH; Gane E; Moyes C; Borman B; Cunningham C
    Gut; 2015 Jun; 64(6):966-72. PubMed ID: 25006011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
    El-Serag HB; Davila JA
    Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship status and other demographic influences on survival in patients with ovarian cancer.
    Gardner AB; Sanders BE; Mann AK; Liao CI; Eskander RN; Kapp DS; Chan JK
    Int J Gynecol Cancer; 2020 Dec; 30(12):1922-1927. PubMed ID: 32920535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of treatment modalities for hepatocellular carcinoma at stages T1 and T2: A preliminary analysis based on the Surveillance, Epidemiology, and End Results registry database.
    Han B; Yao H; Shao L; Guo X; Han L; Gomes Romeiro F; Mancuso A; Qi X
    J BUON; 2018; 23(3):611-621. PubMed ID: 30003727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.
    Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA
    Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and management of hepatocellular carcinoma among Māori and non-Māori New Zealanders.
    Chamberlain J; Sarfati D; Cunningham R; Koea J; Gurney J; Blakely T
    Aust N Z J Public Health; 2013 Dec; 37(6):520-6. PubMed ID: 24892150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Earlier presentation and application of curative treatments in hepatocellular carcinoma.
    Ulahannan SV; Duffy AG; McNeel TS; Kish JK; Dickie LA; Rahma OE; McGlynn KA; Greten TF; Altekruse SF
    Hepatology; 2014 Nov; 60(5):1637-44. PubMed ID: 24996116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening.
    Chen T; Kharazmi E; Fallah M
    JAMA Netw Open; 2023 Apr; 6(4):e238893. PubMed ID: 37074714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
    White DL; Thrift AP; Kanwal F; Davila J; El-Serag HB
    Gastroenterology; 2017 Mar; 152(4):812-820.e5. PubMed ID: 27889576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Striking Racial/Ethnic Disparities in Liver Cancer Incidence Rates and Temporal Trends in California, 1988-2012.
    Pham C; Fong TL; Zhang J; Liu L
    J Natl Cancer Inst; 2018 Nov; 110(11):1259-1269. PubMed ID: 29617913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Radical Cystectomy and Urinary Diversion on Suicidal Death in Patients With Bladder Cancer.
    Klaassen Z; DiBianco JM; Jen RP; Harper B; Yaguchi G; Reinstatler L; Woodard C; Moses KA; Terris MK; Madi R
    J Wound Ostomy Continence Nurs; 2016; 43(2):152-7. PubMed ID: 26680629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial and Ethnic Differences in Socioeconomic Position and Risk of Childhood Acute Lymphoblastic Leukemia.
    Wang L; Gomez SL; Yasui Y
    Am J Epidemiol; 2017 Jun; 185(12):1263-1271. PubMed ID: 28369160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.